Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Bristol-Myers Gets SEC Subpoena In Foreign Bribery Probe

04/26/2012 | 01:01pm US/Eastern
Recommend:
0
   By Peter Loftus 
   Of  
 

Drug maker Bristol-Myers Squibb Co. (>> Bristol Myers Squibb Co.) said it has received a subpoena from the U.S. Securities and Exchange Commission as part of an investigation into bribery overseas.

Bristol-Myers said the subpoena received in March seeks information related to sales and marketing practices in "various countries."

The New York-based company said in a quarterly report filed Thursday with the SEC that it was cooperating with the government. A spokeswoman declined comment beyond the information in Thursday's SEC filing.

Bristol-Myers, which sells the anti-clotting drug Plavix, previously disclosed that the SEC was investigating the activities of the company's units in Germany, concerning potential violations of the U.S. Foreign Corrupt Practices Act, or FCPA.

U.S. authorities in recent years have stepped up enforcement of the FCPA, which bars U.S. companies from bribing foreign officials to obtain or retain business. Multinational drug and medical-device makers based in the U.S. have been among the targets of enforcement.

Last year, Johnson & Johnson (>> Johnson & Johnson) agreed to pay nearly $80 million to resolve allegations that it paid bribes to doctors in three European countries, as well as kickbacks to Iraq to illegally obtain business under former leader Saddam Hussein.

Other drug makers--including Pfizer Inc. (>> Pfizer Inc.), Merck & Co. (>> Merck & Co., Inc.) and Eli Lilly & Co. (>> Eli Lilly & Co.)--also have been the subjects of federal inquiries regarding the FCPA.

-By Peter Loftus, Dow Jones Newswires; +1-215-982-5581; peter.loftus@dowjones.com

Recommend :
0
React to this article
Latest news on BRISTOL-MYERS SQUIBB CO
16m ago BRISTOL MYERS SQUIBB : An Application for the Trademark "BRISTOL-MYERS SQUIBB FO..
1h ago BRISTOL MYERS SQUIBB : Studies from Bristol-Myers Squibb Yield New Data on Antit..
3h ago BRISTOL MYERS SQUIBB : Data on Crystal Engineering Reported by Researchers at Br..
3h ago BRISTOL MYERS SQUIBB : Trademark Application for "IO IMMUNO-ONCOLOGY BRIDGE BUIL..
4h ago BRISTOL MYERS SQUIBB : Studies from Bristol-Myers Squibb Provide New Data on Sch..
7h ago BRISTOL MYERS SQUIBB : Technical Coverage on Pharma Stocks -- Teva Pharmaceutica..
8h ago BRISTOL MYERS SQUIBB : and Pfizer to Present New Data on Eliquis® (apixaban) at ..
8h ago BRISTOL MYERS SQUIBB : and Celgene Enter Clinical Collaboration Agreement to Eva..
5d ago BRISTOL MYERS SQUIBB : Assigned Patent
7d ago BRISTOL MYERS SQUIBB : Trademark Application for "XELTUZIQ" Filed by Bristol-Mye..
Advertisement
Chart
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Income Statement Evolution
Bristol-Myers Squibb Co : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF